Skip to main content
BrainsWay Ltd. (BWAY)
NASDAQ: BWAY · Real-Time Price · USD
12.66
+0.32 (2.59%)
At close: Mar 9, 2026, 4:00 PM EDT
12.65
-0.01 (-0.08%)
After-hours: Mar 9, 2026, 7:15 PM EDT

BrainsWay Revenue

BrainsWay had revenue of $13.51M in the quarter ending September 30, 2025, with 28.66% growth. This brings the company's revenue in the last twelve months to $49.09M, up 27.08% year-over-year. In the year 2024, BrainsWay had annual revenue of $41.02M with 29.04% growth.

Revenue (ttm)
$49.09M
Revenue Growth
+27.08%
P/S Ratio
9.96
Revenue / Employee
$409,117
Employees
120
Market Cap
489.13M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202441.02M9.23M29.04%
Dec 31, 202331.79M4.61M16.96%
Dec 31, 202227.18M-2.48M-8.36%
Dec 31, 202129.66M7.60M34.46%
Dec 31, 202022.06M-1.04M-4.52%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Varex Imaging 854.40M
Orthofix Medical 822.31M
Avanos Medical 701.20M
Bioventus 568.09M
OrthoPediatrics 236.35M
Cytek Biosciences 201.49M
SI-BONE 200.93M
Pacific Biosciences of California 160.01M
Revenue Rankings

BWAY News

More News